Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
Current Pharmaceutical Design|July 13, 2017
The Tat/P-TEFb Protein-Protein Interaction Determining Transcriptional Activation of HIVKaori Asamitsu, Takashi OkamotoJournal of Biochemistry|February 18, 2021
Potential roles of G-quadruplex structures in RNA granules for physiological and pathological phase separationSefan Asamitsu, Norifumi ShiodaMolecules (Basel, Switzerland)|April 21, 2018
HIV Tat/P-TEFb Interaction: A Potential Target for Novel Anti-HIV TherapiesKaori Asamitsu, Koh Fujinaga, Takashi OkamotoPlos One|February 9, 2017
MD simulation of the Tat/Cyclin T1/CDK9 complex revealing the hidden catalytic cavity within the CDK9 molecule upon Tat bindingKaori Asamitsu, Takatsugu Hirokawa, Takashi OkamotoBiophysics and Physicobiology|May 12, 2021
Application of fluorescent-based technology detecting protein-protein interactions to monitor the binding of hepatitis B virus X protein to DNA-damage-binding protein 1Katsumi Omagari, Kaori Asamitsu, Yasuhito TanakaScience (New York, N.Y.)|December 6, 1996
Interplane Tunneling Magnetoresistance in a Layered Manganite CrystalKimura, Tomioka, Kuwahara, et al.Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|December 3, 2019
[The potential of G-quadruplexes as a therapeutic target for neurological diseases]Norifumi Shioda, Yasushi Yabuki, Sefan AsamitsuChemistry (Weinheim an Der Bergstrasse, Germany)|July 28, 2018
Ligand Design to Acquire Specificity to Intended G-Quadruplex StructuresSefan Asamitsu, Toshikazu Bando, Hiroshi SugiyamaCell Chemical Biology|August 17, 2019
Switching Off Cancer-Causing Telomerase Using Small MoleculesSefan Asamitsu, Norifumi Shioda, Hiroshi SugiyamaBiochemistry and Biophysics Reports|April 15, 2025
Drug design for cyclin-dependent kinase 9 (CDK9) inhibitors <i>in silico</i>Kaori Asamitsu, Takatsugu Hirokawa, Takashi OkamotoPageof 9